Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
Patents for C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
05/2003
05/20/2003US6566525 Preparation of N-substituted-hydroxycycloalkylamine derivatives
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003040080A2 Lipoxin a4 analogs
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/08/2003US20030087918 Substituted with purine or pyrimidine bases
05/07/2003EP0730738B1 Metal chelate containing compositions for use in chemiluminescent assays
05/06/2003US6559323 Degradation of hydrazone compound to diazo compound; catalysis with transition metal; reaction with sulfide
05/06/2003US6559109 1,3-Oxathianes as perfuming and flavoring ingredients
05/02/2003EP1305292A1 Biphenyl carboxamides
04/2003
04/30/2003CN1414955A Nitro-sulfobenzamides compound
04/24/2003US20030078287 For controlling plant and animal pests
04/23/2003EP1149088B1 Method of producing dimethyl sulfite
04/17/2003WO2003031431A1 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
04/16/2003EP0971913B1 Process for the production of semi synthetic statins via novel intermediates
04/16/2003EP0674634B1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties
04/09/2003EP0799220B1 Polymerisable monomers and polymers
04/03/2003US20030065056 A five membered ring containing a ketone or thione group and having atleast 2 sulfur atom when its carbonate or one thio and one sulfur when its thione compound, and a compound having two or more acidic groups
04/01/2003US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1
03/2003
03/27/2003US20030060456 Such as 4-(2,3-dihydro-1-benzothien-5-yloxy)-3-((methylamino) methyl)-benzenesulfonamide for use as serotonin re-uptake inhibitors (SSRIs) in treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder
03/18/2003US6534532 Carbanilides as pesticides
03/12/2003EP1189898B1 Process for the synthesis of n-(4-cyano-3-trifluoromethylphenyl)-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropionamide
03/06/2003WO2003018029A1 Anti-bacterial agents based upon oxoanion binding
03/06/2003CA2455504A1 Anti-bacterial agents based upon oxoanion binding
02/2003
02/25/2003US6525197 Producing chemical intermediates for such as epothilone or epothilone analogues synthesis
02/25/2003US6525072 Prevention and treatment of cellular disorders such as cancer
02/11/2003US6518425 A process for producing a 1,3-oxathiolane nucleoside comprising reacting a 5-halo-2-protected-oxymethyl-1,3-oxathiolane with a silylated purine or pyrimidine without the addition of a Lewis acid or an additional base to the reaction
02/05/2003CN1100774C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
01/2003
01/30/2003WO2002085884A8 A process for the stereoselective preparation of insecticide 6,7,8,9,10-10-hexahalo-1,5,5a,6,9,9a-hexahydro-6,9-methano-2,4,3-benzodioxathiepin-3-oxide
01/29/2003CN1100055C Piperazine and piperidine compounds
01/28/2003US6512135 2-methyl-3-(protected hydroxy) benzyl chloride; use making nelfinavir mesylate
01/22/2003CN1392147A Aromatic cyclic polyketone oligomer and its preparing method
01/09/2003WO2003002557A1 Novel compounds for use as photoinitiators
01/07/2003US6503897 N-Formylhydroxylamine derivatives; veterinary medicine; grampositive and gramnegative bacteria
12/2002
12/27/2002WO2002102796A1 Stereoselective method for the preparation of nucleoside analogues
12/25/2002CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides
12/18/2002CN1096458C 2-hetaroylcyclohexane-1,3-diones
12/17/2002US6495714 Method for producing alkanesulfonic acids
12/17/2002US6495643 Ring opening polymerization of such as 6-methylene-1,4-dithiepane optionally with methyl methacrylate; minimizing shrinkage; high molecular weight; such as amide, ester or carbonate backbone groups; adhesives, composites, lenses
12/04/2002EP1261598A1 Internal 1,15-lactones of fluprostenol and related prostaglandin f2alpha analogs and their use in the treatment of glaucoma and intraocular hypertension
11/2002
11/28/2002US20020177622 Neuroprotectants; enhancing cognition
11/27/2002EP1260555A1 Resin compositions
11/07/2002US20020165226 Estrogen receptor modulators
11/06/2002EP1144374A4 Methods for the production of sulfurized diphenyloxides and compositions made therefrom
11/05/2002US6476022 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods
10/2002
10/31/2002WO2002085884A1 A process for the stereoselective preparation of insecticide 6,7,8,9,10-10-hexahalo-1,5,5a,6,9,9a-hexahydro-6,9-methano-2,4,3-benzodioxathiepin-3-oxide
10/31/2002US20020161236 2-methyl-3-(protected hydroxy) benzyl chloride; use making nelfinavir mesylate
10/24/2002US20020155960 4,4-dialkyl- or dialkenyl- substituted; perfumed soaps, shower or bath gels, shampoos, body deodorants and antiperspirants, ambient air deodorants, liquid or solid detergents for textile or dishes
10/17/2002WO2002081464A1 Benzoaxathiepin derivatives and their use as medicines
10/17/2002WO2001057015A9 INTERNAL 1,15-LACTONES OF FLUPROSTENOL AND RELATED PROSTAGLANDIN F2α ANALOGS AND THEIR USE IN THE TREATMENT OF GLAUCOMA AND INTRAOCULAR HYPERTENSION
10/16/2002EP1248777A2 Tricyclic compounds with antiviral activity
10/15/2002US6465661 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
10/10/2002US20020147234 Nitrate esters and methods of making same
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/03/2002US20020143194 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers
10/02/2002CN1372563A Oxathiepino [6,5-b] dihydropyridines, and related compositions and methods
10/02/2002CN1372539A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
09/2002
09/26/2002US20020137789 Anticancer agents
09/25/2002EP1242386A1 Nitro-sulfobenzamides
09/25/2002CN1371279A Metabolites of ecteinascidin 743
09/19/2002US20020132852 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
09/05/2002DE10109856A1 Use of N-phenyl arylamide for treating or preventing chronic or acute hepatitis B viral infections in humans or animals, including co-infections with hepatitis D virus
09/03/2002US6444623 Reacting diphenyl oxide with elemental sulfur in presence of molecular sieve as solid acid catalyst
08/2002
08/28/2002EP1233956A1 Bryostatin analogues, synthetic methods and uses
08/22/2002WO2002032377A3 Estrogen receptor modulators
08/22/2002US20020115654 New compounds, their preparation and use
08/14/2002CN1364162A Alpha-phenyl-beta-ketosulfone
08/07/2002EP1229032A2 1,3-oxathianes as perfuming and flavouring ingredients
07/2002
07/31/2002EP0888334B1 2-hetaroylcyclohexane-1,3-diones
07/25/2002WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
07/25/2002CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
07/23/2002US6423861 Method of producing dimethyl sulfite
07/18/2002WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
07/11/2002US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
07/04/2002WO2002032373A3 Estrogen receptor modulators
06/2002
06/18/2002US6407285 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
06/18/2002US6406913 Analyzing a sample, treating with energy and detection a signal
05/2002
05/30/2002WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
05/23/2002WO2002039816A1 Improved endosulfan formulation and methods of use thereof
05/23/2002CA2427876A1 Improved endosulfan formulation and methods of use thereof
05/22/2002EP1053215B1 Methods for preparing macrocyclic products by ring-closing diine metathesis
05/21/2002US6392067 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
05/16/2002US20020058280 Metal chelate containing compositions for use in chemiluminescent assays
05/15/2002CN1084745C Method for preparing 1,3-oxythiapentane and its derivatives
05/07/2002US6384289 Reacting a 1,4-bis/1,3-dioxa-, dithia- or oxathia- 4,5, or 6-member cycloalk-2-yl/benzene, a fluorinating compound and a bromine-containing compound in a solvent at low temperatures; simplification
05/02/2002US20020052400 Substituted O- and/or S heterocyclic compounds; powerful ligands for melatoninergic receptors.
05/02/2002EP1200446A1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS
04/2002
04/30/2002US6380388 Activity against retroviruses such as human immunodeficiency virus (hiv), hepatitis b virus (hbv), and human t-lymphotropic virus
04/30/2002CA2059787C Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient
04/25/2002WO2002032377A2 Estrogen receptor modulators
04/25/2002WO2002032373A2 Estrogen receptor modulators
04/25/2002CA2424729A1 Estrogen receptor modulators
04/25/2002CA2424726A1 Estrogen receptor modulators
04/24/2002CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
04/18/2002DE10122447A1 Biphenylcarboxamide Biphenylcarboxamides
04/17/2002EP1196371A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
04/16/2002US6372871 Curable liquid mixture of a polymer, preferably acrylic, having a 1,3-oxathiolane-2-thiol and a ketimine, enamine or an aldimine; coatings; adhesives; inks; seals; storage stability
04/03/2002CN1343200A Method for producing alkanesulfonic acids
04/02/2002US6365579 Nitrate esters and their use for neurological conditions
03/2002
03/28/2002US20020038027 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
03/27/2002EP1189898A1 Process for the synthesis of n-(4-cyano-3-trifluoromethylphenyl)-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropionamide
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 25